Abstracts

THE USE OF LESS NEUROTOXIC ANTIRETROVIRALS: SECONDARY ENDPOINTS OF THE MARAND-X STUDY

Despite a high prevalence (30-50%) HIV-associated neurocognitive disorders pathogenesis is incompletely understood. antiretrovirals’ neurotoxicity has been suggested as a potential mechanism. Aim of the study was to measure the change in resting EEG waves, CSF biomarkers and Fibroscan measurements in PLWH with HAND randomized to a less neurotoxic regimen (darunavir/cobicistat, maraviroc, emtricitabine ‘MARAND’) or continuing…

INTRANASAL INSULIN IMPROVES ATTENTION AND MEMORY IN PEOPLE WITH HIV

Despite suppression of HIV replication with antiretroviral therapies (ART), cognitive impairment (CI) remain prevalent in virally suppressed people with HIV (VS-PWH). Although the precise mechanisms for these residual CI are not fully understood, there is considerable evidence that brain energy metabolism is progressively impaired in VS-PWH. We hypothesized that intranasal insulin (INI) would enhance brain…

STATIN USE AND COGNITIVE PERFORMANCE IN THE MULTICENTER AIDS COHORT STUDY

Cardiovascular and cerebrovascular ischemic disease risk factors are associated with cognitive impairment in HIV seropositive individuals. Hypercholesterolemia, one such risk factor, is often treated with statin medications. Statin medications have both lipid lowering effect and anti-inflammatory properties, can improve endothelial function, and enhance dynamic blood flow in cerebral small vessels, which could potentially benefit cognitive…

REVERSIBILITY OF SLEEP DISTURBANCES AFTER SWITCHING FROM DTG/3TC/ABC TO DRV/C/FTC/TAF

Evidence supports switching DTG/3TC/ABC in patients complaining about insomnia. However, there is unknown if the benefit observed could also apply to non-complaining patients displaying sleep disturbances in self-reported questionnaires used as screening tools, such as the Pittsburg sleep quality index (PSQI). We designed the DETOX study, as an open label, randomized (1:1), multicenter, pilot clinical…

VASCULAR INJURY MARKERS ASSOCIATED WITH COGNITIVE IMPAIRMENT IN HIV PATIENTS ON ART

HIV-associated neurocognitive disorders (HAND) remain prevalent despite viral suppression on current antiretroviral therapy (ART). Cerebrovascular disease contributes to HAND, but biomarkers that distinguish vascular cognitive impairment from other types of HAND remain unclear. In this cross-sectional study, we investigated relationships between plasma and CSF vascular, inflammation, and CNS injury markers, HAND, and cerebrovascular disease in…

BASELINE MONOCYTE HIV RNA PREDICTS BLUNTED COGNITIVE TRAJECTORIES IN ACUTE INFECTION

Even when instituted during acute HIV infection (AHI), antiretroviral therapy (ART) does not completely prevent brain injury. Peripheral biomarkers of monocyte/macrophage activation are strong indicators of brain abnormalities in HIV. Whether early establishment of HIV in monocytes contributes to viral persistence and brain injury remains unknown. Here we determined the detectability of HIV RNA in…